Aadi Bioscience Inc.

NASDAQ: AADI · Real-Time Price · USD
2.05
-0.05 (-2.38%)
At close: Mar 18, 2025, 3:59 PM

Aadi Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 7.14M 7.24M 7.21M 6.18M 5.35M 6.33M 5.96M 6.2M 5.87M 5.23M 4.25M 3.44M 2.31M 1M n/a n/a 120K
Cost of Revenue
n/a 760K 790K 804K 778K 652K 927K 697K 656K 529K 222K 593K 341K 179K 110K 137.55K 11.67K 16.78K
Gross Profit
n/a 6.38M 6.45M 6.41M 5.4M 4.7M 5.4M 5.26M 5.55M 5.34M 5M 3.65M 3.1M 2.13M 890K -137.55K -11.67K 103.22K
Operating Income
-54.75M -15.22M -18.95M -13.41M -15.58M -19.51M -17.71M -17.85M -19.55M -16.82M -15.47M -15.04M -18.36M -13.81M -15.95M -87.31M -4.77M -4.36M
Interest Income
1.98M 791K 676K 906K 1.06M 1.28M 1.5M 1.6M 1.64M 1.66M 1.61M 620K 158K 15K 12K n/a 1K n/a
Pretax Income
-52.62M 73.02M -18.27M -12.55M -14.58M -18.29M -16.27M -16.3M -17.97M -15.22M -13.92M -14.47M -18.26M -13.86M -15.99M -87.09M -4.41M -4.44M
Net Income
-52.62M 73.02M -18.27M -12.55M -14.58M -18.29M -16.27M -16.3M -17.97M -13.68M -13.91M -13.32M -18.27M -13.9M -15.99M -87.09M -4.41M -4.44M
Selling & General & Admin
5.94M 12.81M 11.05M 7.19M 7.89M 10.62M 10.35M 11.22M 11.78M 11.21M 11.11M 9.91M 10.01M 9.15M 9.72M 7.4M 4.05M 2.14M
Research & Development
48.81M 8.79M 14.35M 10M 13.09M 13.59M 12.77M 11.89M 13.31M 10.96M 9.37M 8.77M 7.73M 6.79M 7.23M 5.75M 3.04M 3.64M
Other Expenses
n/a n/a n/a 2.64M n/a n/a n/a 697K n/a n/a n/a n/a n/a n/a n/a 380K 2.37M -1.17M
Operating Expenses
54.75M 21.6M 25.4M 19.82M 20.98M 24.21M 23.11M 23.81M 25.09M 22.16M 20.48M 18.69M 17.73M 15.94M 16.95M 13.15M 4.77M 4.36M
Interest Expense
n/a n/a -308K 38K 58K 58K 57K 58K 58K 58K 57K 58K 58K 58K 57K 157K 227K 224K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.96M n/a n/a n/a n/a n/a n/a 1.57M
Cost & Expenses
n/a 22.36M 26.19M 20.63M 21.76M 24.86M 24.04M 23.81M 25.75M 22.69M 20.7M 19.28M 18.07M 16.12M 16.95M 13.15M 4.77M 4.36M
Income Tax Expense
n/a n/a n/a n/a n/a 6.72K n/a -44K 15K -1.54M -9K -1.16M 9K 43K 57K 154K 2K -77.15K
Shares Outstanding (Basic)
69.08M 39.64M 27.09M 24.74M 27.01M 26.98M 26.97M 26.95M 26.88M 26.86M 26.84M 21.27M 20.97M 20.91M 20.89M 9.51M 9.51M 3.15M
Shares Outstanding (Diluted)
69.08M 39.93M 27.09M 24.74M 27.01M 26.98M 26.97M 26.95M 26.88M 26.86M 26.84M 21.27M 20.97M 20.91M 20.89M 9.51M 9.51M 3.15M
EPS (Basic)
-0.76 1.84 -0.67 -0.47 -0.54 -0.68 -0.6 -0.6 -0.67 -0.51 -0.52 -0.63 -0.87 -0.66 -0.77 -9.16 -0.46 -1.41
EPS (Diluted)
-0.76 1.83 -0.67 -0.47 -0.54 -0.68 -0.6 -0.6 -0.67 -0.51 -0.52 -0.63 -0.87 -0.66 -0.77 -9.16 -0.46 -1.41
EBITDA
-54.75M 73.07M -18.9M -12.46M -14.47M -18.18M -16.17M -16.2M -17.87M -15.13M -13.82M -14.29M -18.08M -13.66M -15.82M -86.79M -4.4M -5.6M
EBIT
n/a 73.02M -18.95M -12.51M -14.53M -18.23M -16.21M -16.24M -17.91M -15.16M -13.87M -14.42M -18.2M -13.8M -15.93M -86.93M -4.41M -4.44M
Depreciation & Amortization
n/a 57K 47K 47K 49K 50K 44K 44K 43K 38K 46K 125K 118K 140K 110K 137.55K 11.67K 16.78K